ASSET PURCHASE AGREEMENT by and between CARDINAL HEALTH 414, LLC and NAVIDEA BIOPHARMACEUTICALS, INC. Dated November 23, 2016Asset Purchase Agreement • November 30th, 2016 • Navidea Biopharmaceuticals, Inc. • In vitro & in vivo diagnostic substances • Delaware
Contract Type FiledNovember 30th, 2016 Company Industry JurisdictionThis ASSET PURCHASE AGREEMENT, dated November 23, 2016 (this “Agreement”), is between Cardinal Health 414, LLC, a Delaware limited liability company (“Buyer”), and Navidea Biopharmaceuticals, Inc., a Delaware corporation (“Seller”). Buyer and Seller are each referred to herein as a “Party” and, collectively, as the “Parties.”